Pyrotinib as a therapeutic for HER2-positive breast cancer.

ABSTRACT:

SUBMITTER: Kioutchoukova I 

PROVIDER: S-EPMC10331451 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature